Flow diversion shows high rate of visual improvement in patients with paraclinoid aneurysms

NewsGuard 100/100 Score

Aneurysms of the paraclinoid region of the internal carotid artery (ICA) and the interventions used to treat them often result in visual impairment.

Researchers at Brigham and Women's Hospital, however, found that flow diversion demonstrates a higher rate of visual improvement and a lower rate of visual decline in patients with these types of aneurysms. Results from this new study were presented at the Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting today in Boston.

Because of the proximity of paraclinoid aneurysms to the optic nerve and the ophthalmic artery, between 16 percent and 53 percent of patients present with visual deficits. And while flow diversion is increasingly used throughout endovascular neurosurgery, few studies have reported the visual outcomes of treating these aneurysms with this technique, or compared it to coiling or clipping.

Researchers performed a retrospective analysis of patients with paraclinoid aneurysms who were treated at Brigham & Women's Hospital with a Pipeline embolization device (PED). Visual deficits were improved in 8 patients (80 percent) following treatment. No patients experienced sustained worsening of their existing visual impairment; however, one patient acquired postoperative iatrogenic vision impairment (5 percent).

"We compiled visual outcome data for 29 patients presenting with 32 paraclinoid aneurysms treated at our site with the Pipeline embolization device, 12 of whom presented with visual impairment," said Michael Silva, a medical student at Harvard Medical School working with Dr. Mohammad A. Aziz-Sultan on the project. "We found a high rate of visual improvement and a low rate of complications in these patients, especially compared to historical visual outcomes reported for coiling and clipping of paraclinoid aneurysms."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds lack of preventative care for children with sickle cell anemia